scholarly journals Effect of a Nationwide Universal HBV Vaccination Program and Catch-up Vaccination Campaign on HBV Prevalence in Children

2021 ◽  
Vol 27 (3) ◽  
pp. 148-152
Author(s):  
Selma Tosun ◽  
Serol Deveci ◽  
Erhun Kasırga
Keyword(s):  
Vaccination Campaign ◽  
Vaccination Program ◽  
Hbv Vaccination ◽  
Hbv Prevalence ◽  
Catch Up

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program

Sexual Health ◽  
2007 ◽  
Vol 4 (3) ◽  
pp. 165 ◽  
Author(s):  
Shalini Kulasingam ◽  
Luke Connelly ◽  
Elizabeth Conway ◽  
Jane S. Hocking ◽  
Evan Myers ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cost Effectiveness ◽  
Hpv Vaccine ◽  
Screening Program ◽  
Herd Immunity ◽  
Vaccination Program ◽  
Catch Up ◽  
The Cost ◽  
Current Screening

Background: The cost-effectiveness of adding a human papillomavirus (HPV) vaccine to the Australian National Cervical Screening Program compared to screening alone was examined. Methods: A Markov model of the natural history of HPV infection that incorporates screening and vaccination was developed. A vaccine that prevents 100% of HPV 16/18-associated disease, with a lifetime duration of efficacy and 80% coverage offered through a school program to girls aged 12 years, in conjunction with current screening was compared with screening alone using cost (in Australian dollars) per life-year (LY) saved and quality-adjusted life-year (QALY) saved. Sensitivity analyses included determining the cost-effectiveness of offering a catch-up vaccination program to 14–26-year-olds and accounting for the benefits of herd immunity. Results: Vaccination with screening compared with screening alone was associated with an incremental cost-effectiveness ratio (ICER) of $51 103 per LY and $18 735 per QALY, assuming a cost per vaccine dose of $115. Results were sensitive to assumptions about the duration of vaccine efficacy, including the need for a booster ($68 158 per LY and $24 988 per QALY) to produce lifetime immunity. Accounting for herd immunity resulted in a more attractive ICER ($36 343 per LY and $13 316 per QALY) for girls only. The cost per LY of vaccinating boys and girls was $92 052 and the cost per QALY was $33 644. The cost per LY of implementing a catch-up vaccination program ranged from $45 652 ($16 727 per QALY) for extending vaccination to 14-year-olds to $78 702 ($34 536 per QALY) for 26-year-olds. Conclusions: These results suggest that adding an HPV vaccine to Australia’s current screening regimen is a potentially cost-effective way to reduce cervical cancer and the clinical interventions that are currently associated with its prevention via screening alone.

scholarly journals Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study

Vaccine ◽  
2015 ◽  
Vol 33 (20) ◽  
pp. 2387-2394 ◽  
Author(s):  
Karen Canfell ◽  
Sam Egger ◽  
Louiza S. Velentzis ◽  
Jessica Darlington Brown ◽  
Dianne L. O’Connell ◽  
...  
Keyword(s):  
Young Adult ◽  
Observational Study ◽  
Hpv Vaccination ◽  
Vaccine Uptake ◽  
Vaccination Program ◽  
Adult Women ◽  
Young Adult Women ◽  
Catch Up

HPV Awareness in Higher Risk Young Women: Is There a Need for an HPV Catch-Up Vaccination Program?

2014 ◽  
Vol 27 (2) ◽  
pp. e62
Author(s):  
Stephanie Ahken ◽  
Amanda Black ◽  
Tania Dumont ◽  
Nathalie Fleming
Keyword(s):  
Young Women ◽  
Vaccination Program ◽  
Catch Up ◽  
Hpv Awareness

scholarly journals Recurrence of measles in central Italy: the experience of a hospital in Rome

2019 ◽  
Vol 34 (1) ◽  
Author(s):  
Andrea Petrucca ◽  
Antonella Alari ◽  
Styliani Papadopoulou ◽  
Crisitina Petrucci ◽  
Iolanda Santino
Keyword(s):  
Healthcare Workers ◽  
Adult Population ◽  
Vaccination Campaign ◽  
Central Italy ◽  
Immunization Coverage ◽  
Public Health Issue ◽  
High Morbidity ◽  
Major Public Health Issue ◽  
Measles Outbreak ◽  
Catch Up

Measles continue to be a major public health issue worldwide with high morbidity and mortality rates. The disease is still endemic in Europe and during 2017 a vast outbreak was described in Italy, Romania and Hungary, which led to thousands of new cases and several deaths. In Italy, 3931 confirmed cases of measles were reported to the Italian national surveillance system from many Italian administrative regions; Lazio, in central Italy, exhibited the highest number of infected patients 1322 (33.63%) and as well as the highest incidence. In this study, we describe the results of a retrospective analysis, carried out during 2016 and 2017, concerning the measles antibody prevalence in patients and healthcare workers attending the Sant’Andrea Hospital of Rome (Lazio). A total of 94 patients (median 30 years of age) were screened in 2016, and 316 (median 40 years of age) during 2017, with an increase of 236% compared to previous year. During 2017, 41 confirmed cases of measles were reported while none in 2016 (P<0.007), and we found a suboptimal immunization coverage in our cohort of patients. Furthermore, measles surveillance of Sant’Andrea healthcare workers during the study period involved 208 personnel units (median >47 years of age) and only one confirmed measles infection was recorded in 2017. These results suggest that there is still an unvaccinated portion of the adult population, who sustain the endemic circulation of measles in Italy. In addition to reach herd immunization on children of 2 years old, catch-up vaccination campaign targeting adult population in Italy and other European countries needs to be implemented to prevent future measles outbreak.

scholarly journals Epidemiological characteristics of measles from 2000 to 2014: Results of a measles catch-up vaccination campaign in Xianyang, China

2017 ◽  
Vol 10 (5) ◽  
pp. 624-629 ◽  
Author(s):  
Rong-Qiang Zhang ◽  
Hong-Bing Li ◽  
Feng-Ying Li ◽  
Li-Xin Han ◽  
Yong-Min Xiong
Keyword(s):  
Vaccination Campaign ◽  
Catch Up ◽  
Epidemiological Characteristics

scholarly journals Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014

2018 ◽  
Vol 23 (6) ◽  
Author(s):  
Alessandro Miglietta ◽  
Chantal Quinten ◽  
Pier Luigi Lopalco ◽  
Erika Duffell
Keyword(s):  
European Union ◽  
Hepatitis B ◽  
Poisson Regression ◽  
Vaccine Coverage ◽  
Hbv Infection ◽  
European Economic Area ◽  
Hbv Vaccination ◽  
Economic Area ◽  
Acute Hepatitis B ◽  
Catch Up

Hepatitis B prevention in European Union/European Economic Area (EU/EEA) countries relies on vaccination programmes. We describe the epidemiology of acute hepatitis B virus (HBV) at country and EU/EEA level during 2006–2014. Using a multi-level mixed-effects Poisson regression model we assessed differences in the acute HBV infection notification rates between groups of countries that started universal HBV vaccination before/in vs after 1995; implemented or not a catch-up strategy; reached a vaccine coverage ≥ 95% vs < 95% and had a hepatitis B surface antigen prevalence ≥ 1% vs < 1%. Joinpoint regression analysis was used to assess trends by groups of countries, and additional Poisson regression models to evaluate the association between three-dose HBV vaccine coverage and acute HBV infection notification rates at country and EU/EEA level. The EU/EEA acute HBV infection notification rate decreased from 1.6 per 100,000 population in 2006 to 0.7 in 2014. No differences (p > 0.05) were found in the acute HBV infection notification rates between groups of countries, while as vaccine coverage increased, such rates decreased (p < 0.01). Countries with universal HBV vaccination before 1995, a catch-up strategy, and a vaccine coverage ≥ 95% had significant decreasing trends (p < 0.01). Ending HBV transmission in Europe by 2030 will require high vaccine coverage delivered through universal programmes, supported, where appropriate, by catch-up vaccination campaigns.

Opportunities to increase rates of human papillomavirus vaccination in the New South Wales school program through enhanced catch-up

Sexual Health ◽  
2016 ◽  
Vol 13 (6) ◽  
pp. 536 ◽  
Author(s):  
Christine Staples ◽  
Michelle Butler ◽  
Jennifer Nguyen ◽  
David N. Durrheim ◽  
Patrick Cashman ◽  
...  
Keyword(s):  
High School Students ◽  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
Vaccine Coverage ◽  
Hpv Vaccination ◽  
Vaccination Program ◽  
Completion Rates ◽  
School Program ◽  
Human Papillomavirus Vaccination ◽  
Catch Up

Background The National Human Papillomavirus (HPV) Vaccination Program provides HPV vaccine to high school students through school-based vaccination. We aimed to: 1) assess the vaccine completion rates achieved when general practice is used for completing doses missed at school; 2) estimate the extent of under-notification by general practices of vaccine doses administered; and 3) assess the reasons reported by parents of students for non-completion of HPV vaccination. Methods: A postal survey was conducted of parents and carers of students and identified, using school-program records, as incompletely vaccinated in a large regional area of northern NSW vaccinated during 2010. Information about additional HPV vaccine doses received or reasons for non-completion were sought. Responses were analysed and records cross-checked against the National HPV Vaccination Program Register. Results: Of 660 parents or carers contacted, 207 (31.4%) responded. We found: 1) completion rates increased, an additional 122/207 (45.2%) students had completed all three doses of HPV through their general practitioner (GP); 2) under-notification of GP doses to the National HPV Vaccination Program Register was an issue with only 5/165 (3.0%) reported; 3) the main reason for non-completion was being unaware of the opportunity to catch-up at a GP. Conclusions: Underreporting by GPs of HPV vaccine doses administered and failure to complete courses identifies two opportunities to increase HPV vaccine coverage. These could be addressed by extending provision of catch-up HPV doses in school and by developing practice software solutions for automatic notification of doses from GPs. Reasons given by parents for non-completion, mostly logistical barriers, indicate a high degree of acceptance of HPV vaccination.

A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: Vaccine uptake and knowledge and attitudes of students

Vaccine ◽  
2010 ◽  
Vol 28 (47) ◽  
pp. 7563-7568 ◽  
Author(s):  
Khaled M. Abd Elaziz ◽  
Sahar M. Sabbour ◽  
Sahar A. Dewedar
Keyword(s):  
Vaccination Campaign ◽  
Vaccine Uptake ◽  
Knowledge And Attitudes ◽  
Catch Up

scholarly journals Impact of Rotavirus Vaccine on Premature Infants

2014 ◽  
Vol 21 (10) ◽  
pp. 1404-1409 ◽  
Author(s):  
Jean-Michel Roué ◽  
Emmanuel Nowak ◽  
Grégoire Le Gal ◽  
Thomas Lemaitre ◽  
Emmanuel Oger ◽  
...  
Keyword(s):  
Premature Infants ◽  
Vaccine Coverage ◽  
Vaccination Campaign ◽  
University Hospital ◽  
Vaccination Program ◽  
National Study ◽  
Rotavirus Vaccine ◽  
Term Infants ◽  
Rotavirus Diarrhea ◽  
The Impact

ABSTRACTInfants born preterm are at a higher risk of complications and hospitalization in cases of rotavirus diarrhea than children born at term. We evaluated the impact of a rotavirus vaccination campaign (May 2007 to May 2010) on hospitalizations for rotavirus gastroenteritis in a population of children under 3 years old born prematurely (before 37 weeks of gestation) in the Brest University Hospital birth zone. Active surveillance from 2002 to 2006 and a prospective collection of hospitalizations for rotavirus diarrhea were initiated in the pediatric units of Brest University Hospital until May 2010. Numbers of hospitalizations for rotavirus diarrhea among the population of children born prematurely, before and after the start of the vaccination program, were compared using a Poisson regression model controlling for epidemic-to-epidemic variation. A total of 217 premature infants were vaccinated from 2007 to 2010. Vaccine coverage for a complete course of three doses was 41.9%. The vaccine safety in premature infants was similar to that in term infants. The vaccination program led to a division by a factor of 2.6 (95% confidence interval [CI], 1.3 to 5.2) in the number of hospitalizations for rotavirus diarrhea during the first two epidemic seasons following vaccine introduction and by a factor of 11 (95% CI, 3.5 to 34.8) during the third season. We observed significant effectiveness of the pentavalent rotavirus vaccine on the number of hospitalizations in a population of prematurely born infants younger than 3 years of age. A multicenter national study would provide better assessment of this impact. (This study [Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France (IVANHOE)] has been registered at ClinicalTrials.gov under registration no. NCT00740935.)

scholarly journals Factors Influencing Farmers Participation in the Vaccination Program against Anthrax in Bogor District, Indonesia

2020 ◽  
pp. 29-34
Author(s):  
Chaerul Basri ◽  
Etih Sudarnika ◽  
S Dwidzuriputra
Keyword(s):  
Vaccination Campaign ◽  
Mass Vaccination ◽  
Vaccination Program ◽  
Chi Square ◽  
Vaccination Programs ◽  
Factors Influencing ◽  
Mass Vaccination Campaign ◽  
Chi Square Test ◽  
History Of ◽  
Structured Questionnaire

Bogor District is one of the endemic areas of anthrax cases in Indonesia. The mass vaccination campaign on livestock including goats and sheep needs to be done to prevent the spread of the disease. The willingness of farmers to participate is the main key to the success of this vaccination campaign. This study aimed to identify the factors that influence the willingness of goat and sheep farmers to participate in vaccination programs against anthrax in their farms. A total of 60 goat and sheep farmers were randomly selected from 3 villages located in the region with the highest incidence of cases in Babakan Madang Subdistrict. Data was collected through direct interviews using a structured questionnaire. Analysis to determine risk factors was carried out by chi square test and continued by calculating the value of relative risk (RR) to measure the magnitude of the influence of these factors. The results showed that the factors that influenced the farmers to be willing to participate in the anthrax vaccination program were history that had been directly counseled with RR values 2,844 (95% CI = 1,547-5,288) and history of having constrained to vaccinate their livestock with RR values 1,960 (95% CI = 1,203 - 3,193). Based on these findings it is recommended to increase farmer participation in mass vaccination programs against anthrax can be done through increasing communication, information and education activities and minimizing constraints for farmers to vaccinate their livestock.

Sign in / Sign up

Export Citation Format

Share Document